RxDoctor Payments DataLook up a doctor →

Curtis Healey, MD

Family Medicine · North Ogden, UTNPI 1922021427

Payments from drug & device makers

$14,969in general payments, 2019–2025

Across 909 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • Novo Nordisk$1K
  • Boehringer Ingelheim$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • Amgen$1K
  • plus $8K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK74$1,130
Novo Nordisk84$1,124
Boehringer Ingelheim62$1,124
AstraZeneca52$1,072
Lilly USA, LLC82$1,053
Amgen64$1,003
Astellas Pharma US Inc54$954
AbbVie(2 entities)44$798
Pfizer46$740
Takeda Pharmaceuticals U.S.A., Inc.31$598
Supernus Pharmaceuticals, Inc.22$564
Axsome Therapeutics, Inc.22$399
Johnson & Johnson26$390
Novartis18$347
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC23$336
Sanofi-aventis U.S. LLC22$305
Amarin Pharma, Inc.19$287
Dexcom, Inc.11$188
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)8$186
E.r. Squibb & Sons, L.L.C.12$182
Sumitomo Pharma America, Inc.10$146
Mylan Specialty L.p.7$142
Eisai Inc.9$120
Idorsia Pharmaceuticals US Inc7$105
Exact Sciences6$104
Biohaven Pharmaceutical Holding Company Ltd.6$102
Lundbeck LLC6$99
Genentech USA, Inc.6$91
Daiichi Sankyo Inc.4$85
Abbott5$77
Medtronic(2 entities)5$74
Mannkind Corporation4$69
Strongbridge US Inc.4$67
Sunovion Pharmaceuticals Inc.5$66
Dynavax Technologies Corporation4$64
Actelion Pharmaceuticals US, Inc.2$57
Biogen3$54
Otsuka America Pharmaceutical, Inc.2$52
Merck4$52
Xeris Pharmaceuticals, Inc.3$51
Tandem Diabetes Care, Inc.3$49
Phathom Pharmaceuticals, Inc.3$48
Lucid Diagnostics Inc.3$44
Biohaven Pharmaceuticals, Inc.2$34
Shield Therapeutics Inc2$33
Shire North American Group Inc2$31
Inspire Medical Systems, Inc.2$29
Edwards Lifesciences1$27
Viatris Specialty LLC1$25
Corcept Therapeutics2$24
Seqirus USA Inc1$21
Nestle Healthcare Nutrition Inc.1$20
Teva Pharmaceuticals USA, Inc.1$19
Insulet Corporation1$19
Sanofi Pasteur Inc.1$18
Redhill Biopharma Inc.1$16
BETA Bionics, Inc.1$14
Jazz Pharmaceuticals Inc.1$14
Lifescan, Inc.1$13
Kowa Pharmaceuticals America, Inc.1$12

How this compares

$14,969 in reported general payments places this provider in the 90th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$141,610
Medicare patients
234
Services billed
12,940

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in North Ogden

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →